Bosh sahifaDMN • FRA
add
Diamyd Medical AB
Yopilish kursi
0,14 €
Kunlik diapazon
0,092 € - 0,092 €
Yillik diapazon
0,090 € - 1,80 €
Bozor kapitalizatsiyasi
190,64 mln SEK
Oʻrtacha hajm
1,63 ming
Narx/foyda
-
Dividend daromadliligi
-
Asosiy maydon
STO
Bozor yangiliklari
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (SEK) | fev, 2026info | Y/Y qiyosi |
|---|---|---|
Daromad | 99,00 ming | 15,12% |
Joriy xarajat | 64,34 mln | 43,95% |
Sof foyda | -62,88 mln | -40,14% |
Sof foyda marjasi | -63,51 ming | -21,74% |
Har bir ulushga tushum | — | — |
EBITDA | -63,24 mln | -43,70% |
Amaldagi soliq stavkasi | — | — |
Balans
Jami aktivlari
Jami passivlari
| (SEK) | fev, 2026info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 190,73 mln | 83,83% |
Jami aktivlari | 253,63 mln | 40,22% |
Jami passivlari | 83,84 mln | 20,89% |
Umumiy kapital | 169,80 mln | — |
Tarqatilgan aksiyalar | 137,50 mln | — |
Narxi/balansdagi bahosi | 0,12 | — |
Aktivlardan daromad | -58,47% | — |
Kapitaldan daromad | -80,99% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (SEK) | fev, 2026info | Y/Y qiyosi |
|---|---|---|
Sof foyda | -62,88 mln | -40,14% |
Operatsiyalardan naqd pul | -39,51 mln | 18,40% |
Sarmoyadan naqd pul | -20,11 mln | -4 291,05% |
Moliyadan naqd pul | -2,14 mln | -237,01% |
Naqd pulning sof oʻzgarishi | -62,39 mln | -27,00% |
Boʻsh pul | -19,53 mln | 40,32% |
Haqida
Diamyd Medical AB is a small biotechnology company headquartered in Stockholm, Sweden that focuses on immune modifying therapies for diabetes. The company is developing two products.
The company is headquartered in Stockholm, and maintains a manufacturing facility in Umeå. Wikipedia
Tashkil etilgan
1984
Sayt
Xodimlar soni
41
